Metroticket Calculator for Hepatocellular Carcinoma (HCC) Survival 2.0
Predicts post-liver transplant survival for patients with HCC based on preoperative factors.
If an alpha-fetoprotein (AFP) level is unavailable, consider using the original Metroticket.
Advice
- Discuss results in a multidisciplinary transplant board and in shared decision-making with the patient (prognostic framing, trade-offs, and waiting-list risks).
- Authors proposed a ~70% predicted 5-year HCC-specific survival as a pragmatic threshold for considering listing/activation when otherwise appropriate; follow local policy.
Critical Actions
Allocation rules still govern transplant candidacy; this tool does not override OPTN/UNOS policy.